RGNX — Regenxbio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Regenxbio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	476	457	365	275	235
Net Total Accounts Receivable
Net Total Receivables	43	32.4	28.1	24.8	20.5
Prepaid Expenses
Total Other Current Assets
Total Current Assets	531	519	416	335	278
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	120	192	207	193	171
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	708	1,114	833	574	466
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	81.4	130	130	130	103
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	330	350	317	262	206
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	378	764	516	312	260
Total Liabilities & Shareholders' Equity	708	1,114	833	574	466
Total Common Shares Outstanding